Your browser doesn't support javascript.
loading
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology.
Aktaa, Suleman; Abdin, Amr; Arbelo, Elena; Burri, Haran; Vernooy, Kevin; Blomström-Lundqvist, Carina; Boriani, Giuseppe; Defaye, Pascal; Deharo, Jean-Claude; Drossart, Inga; Foldager, Dan; Gold, Michael R; Johansen, Jens Brock; Leyva, Francisco; Linde, Cecilia; Michowitz, Yoav; Kronborg, Mads Brix; Slotwiner, David; Steen, Torkel; Tolosana, José Maria; Tzeis, Stylianos; Varma, Niraj; Glikson, Michael; Nielsen, Jens Cosedis; Gale, Chris P.
Afiliação
  • Aktaa S; Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
  • Abdin A; Leeds Institute for Data Analytics and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Arbelo E; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Burri H; Internal Medicine Clinic III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg/Saar, Germany.
  • Vernooy K; Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
  • Blomström-Lundqvist C; Institut d'Investigacións Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Boriani G; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
  • Defaye P; Cardiology Department, Geneva University Hospital, Geneva, Switzerland.
  • Deharo JC; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC), Maastricht, the Netherlands.
  • Drossart I; Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden.
  • Foldager D; Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
  • Gold MR; Department of Cardiology, Arrhythmias Unit, University Hospital Grenoble Alps and Grenoble Alps University, Grenoble, France.
  • Johansen JB; Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France.
  • Leyva F; Service de Cardiologie, Hôpital de la Timone, APHM, Marseille, France.
  • Linde C; Drossart (Belguim), ESC Patient Forum, Sophia Antipolis.
  • Michowitz Y; Foldager(Denmark), ESC Patient Forum, Sophia Antipolis, France.
  • Kronborg MB; Division of Cardiology, Medical University of South Carolina, Charleston, SC, USA.
  • Slotwiner D; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Steen T; Department of Cardiology, Aston Medical School, Aston University, Birmingham, UK.
  • Tolosana JM; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.
  • Tzeis S; Department of Medicine, Karolinska Institute, Solna, Sweden.
  • Varma N; Department of Cardiology, Karolinska University Hospital, Solna, Sweden.
  • Glikson M; Cardiology Department, Shaare Zedek Hospital, Affiliated to the Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Nielsen JC; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Gale CP; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Europace ; 24(1): 165-172, 2022 01 04.
Article em En | MEDLINE | ID: mdl-34455442
ABSTRACT

AIMS:

To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults undergoing cardiac pacing. METHODS AND

RESULTS:

Under the auspice of the Clinical Practice Guideline Quality Indicator Committee of the European Society of Cardiology (ESC), the Working Group for cardiac pacing QIs was formed. The Group comprised Task Force members of the 2021 ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, members of the European Heart Rhythm Association, international cardiac device experts, and patient representatives. We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care by constructing a conceptual framework of the management of patients receiving cardiac pacing, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified-Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. Four domains of care were identified (i) structural framework, (ii) patient assessment, (iii) pacing strategy, and (iv) clinical outcomes. In total, seven main and four secondary QIs were selected across these domains and were embedded within the 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization therapy.

CONCLUSION:

By way of a standardized process, 11 QIs for cardiac pacing were developed. These indicators may be used to quantify adherence to guideline-recommended clinical practice and have the potential to improve the care and outcomes of patients receiving cardiac pacemakers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Cardiologia / Terapia de Ressincronização Cardíaca Tipo de estudo: Guideline / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Cardiologia / Terapia de Ressincronização Cardíaca Tipo de estudo: Guideline / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article